Ferinject 500 mg/10 ml (IV Injection or Infusion)

10 ml vial: ৳ 3,430.00

Medicine Details

Product Title, Categories, and Description

  • Ferinject
  • Iron Deficiency Anaemia Treatment
  • Colloidal Iron (III) Hydroxide
  • Carboxymaltose
  • Carbohydrate Polymer
  • Parenteral Iron Preparation
  • Treatment for Intolerance to Oral Iron
  • Treatment for Chronic Kidney Disease
  • Intravenous Iron Repletion
  • Stepwise Dosage & Administration
  • Individual Iron Need Determination
  • Maximum Individual Iron Dose Calculation
  • Post-Iron Repletion Assessments
  • Drug Interaction Studies Absence
  • Contraindications
  • Side Effects
  • Pregnancy & Lactation Precautions
  • Hypersensitivity Monitoring
  • Hypertension Monitoring
  • Laboratory Test Alterations Monitoring
  • Use in Haemodialysis-Dependent CKD
  • Paediatric Population Exclusion
  • Overdose Effects
  • Storage Conditions

Indications

  • Intolerance to Oral Iron
  • Unsatisfactory Response to Oral Iron
  • Non-Dialysis Dependent Chronic Kidney Disease

Dosage & Administration

  • Stepwise Posology Approach
  • Individual Iron Need Determination based on Body Weight and Hb Level
  • Maximum Iron Dose Calculation and Administration
  • Maximum Recommended Cumulative Dose
  • Post-Iron Repletion Assessments Timeline

Interaction

  • No Formal Drug Interaction Studies

Contraindications

  • Hypersensitivity to Active Substance or Excipients
  • Hypersensitivity to Parenteral Iron Products
  • Anaemia Not Attributed to Iron Deficiency
  • Evidence of Iron Overload or Utilisation Disturbances

Side Effects

  • Infrequent and Mild
  • Common: Nausea
  • Common: Headache
  • Common: Dizziness
  • Common: Hypertension
  • Common: Injection Site Reactions
  • Uncommon: Hypersensitivit
  • Uncommon: Dysgeusia
  • Uncommon: Tachycardia
  • Rare: Anaphylactoid Reactions

Pregnancy & Lactation

  • No Well-Controlled Trials in Pregnant Women
  • Concerns about Skeletal Development in Fetus
  • Limited Data on Breastfeeding Women

Precautions & Warnings

  • Serious Hypersensitivity Reactions Monitoring
  • Anaphylactic-Type Reactions Risk
  • Hypertension Monitoring
  • Laboratory Test Alterations Monitoring

Use in Special Populations

  • Maximum Daily Injection Dose in Haemodialysis-Dependent CKD
  • Not Recommended in Children under 14 years

Overdose Effects

  • Potential Iron Accumulation
  • Monitoring of Iron Parameters
  • Consideration of Iron Chelator

Storage Conditions

  • Cool and Dry Storage
  • Avoid Freezing
  • Keep Out of Reach of Children

Related Brands